GuruFocus Updates (Free subscription) | 24/11/2009
By insider. CEO of ResMed Inc. ( RMD ) Kieran Gallahue sells 17,400 shares of RMD on 11/19/2009 at an average price of $50.45 a share. Read more » »
GuruFocus Updates (Free subscription) | 19/11/2009
By insider. COO, Europe of ResMed Inc. ( RMD ) Stein Jacobsen sells 40,000 shares of RMD on 11/17/2009 at an average price of $50 a share. Read more » »
GuruFocus Updates (Free subscription) | 14/11/2009
By insider. Executive Chairman of ResMed Inc. ( RMD ) Peter C Farrell sells 123,334 shares of RMD on 11/11/2009 at an average price of $48.76 a share. Read more » »
GuruFocus Updates (Free subscription) | 12/11/2009
By insider. CEO of ResMed Inc. ( RMD ) Kieran Gallahue sells 7,500 shares of RMD on 11/10/2009 at an average price of $48.92 a share. Read more » »
GuruFocus Updates (Free subscription) | 12/11/2009
By insider. Executive Chairman of ResMed Inc. ( RMD ) Peter C Farrell sells 28,618 shares of RMD on 11/10/2009 at an average price of $48.98 a share. Read more » »
DeviceSpace (Free subscription) | 06/11/2009
Reuters -- Respiratory equipment maker ResMed Inc reported better-than-expected quarterly profit that jumped 50 percent, helped by double-digit sales growth in the Americas.
MarketIntelligenceCenter.com (Free subscription) | 06/11/2009
ResMed (RMD) was downgraded today by analysts at Jefferies & Co. and the stock is now at $47.08, down $2.97 (-5.93%) on volume of 960,509 shares traded. The brokerage reduced RMD to Hold from Buy. Over the last 52 weeks the stock has ranged from a low of $30.53 to a high of $50.63. ResMed stock has been showing support around $48.57 and resistanc...
PR News Wire (Free subscription) | 05/11/2009
SAN DIEGO, Nov. 5 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income results for the quarter ended September 30, 2009. Revenue for the September 2009 quarter was $247.0 million, a 13% increase (a 16% increase on a constant currency basis) over the quarter ended September 30, 2008. For the quarter ended September 30, 2009, income from operations was $52.7 million...
Red Orbit (Free subscription) | 05/11/2009
SAN DIEGO, Nov. 5 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income results for the quarter ended September 30, 2009.
GuruFocus Updates (Free subscription) | 05/11/2009
By insider. Executive Chairman of ResMed Inc. ( RMD ) Peter C Farrell sells 10,000 shares of RMD on 11/02/2009 at an average price of $49.13 a share. Read more » »
BloggingStocks (Free subscription) | 31/10/2009
Filed under: Options , Stocks to Buy New York and Philadelphia have some of the most hardcore fans in Major League Baseball. These fans don't just get excited about a game as big as the World Series, they get stressed out. And stress isn't good for anyone's health, and neither are the hot dogs New York fans will gorge themselves on, or the cheese steaks the Philadelphia fans will wolf down. Plus,...
MarketIntelligenceCenter.com (Free subscription) | 28/10/2009
ResMed (NYSE: RMD) closed yesterday at $49.47. So far the stock has hit a 52-week low of $28.90 and 52-week high of $50.18. ResMed stock has been showing support around 48.62 and resistance in the 50.60 range. Technical indicators for the stock are Bullish and S&P gives RMD a positive 4 STAR (out of 5) buy rating. RMD appears on the Investors Observer Momentum Plays list. For a hedged play o...
GuruFocus Updates (Free subscription) | 28/10/2009
By insider. CEO of ResMed Inc. ( RMD ) Kieran Gallahue sells 5,000 shares of RMD on 10/26/2009 at an average price of $50.01 a share. Read more » »
Red Orbit (Free subscription) | 15/10/2009
SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD), announced today that on Thursday, November 5, 2009, it will release its results for the first quarter of fiscal year 2010, ended September 30, 2009.
MarketIntelligenceCenter.com (Free subscription) | 13/10/2009
ResMed (RMD) was upgraded today by analysts at Credit Suisse and the stock is now at $47.78, up $0.93 (1.99%) on volume of 835,257 shares traded. The analysts upped RMD to Outperform from Neutral. Over the last 52 weeks the stock has ranged from a low of $28.90 to a high of $46.90. ResMed stock has been showing support around $46.34 and resistance ...
Videos